PetMed Express, Inc. (PETS)

USD 5.28

(-5.38%)

Market Cap (In USD)

109.1 Million

Revenue (In USD)

281.06 Million

Net Income (In USD)

-7.46 Million

Avg. Volume

308.08 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.9-7.79
PE
-
EPS
-
Beta Value
0.676
ISIN
US7163821066
CUSIP
716382106
CIK
1040130
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ms. Sandra Y. Campos
Employee Count
-
Website
https://www.1800petmeds.com
Ipo Date
1999-04-26
Details
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.